Summit Therapeutics shares rise after the company says AstraZeneca will make a $2 billion strategic equity investment to help jointly develop drugs with the cancer drugmaker.

Sep 28, 2026 - 18:00
 0  0

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0